))
Episode 06: RxE2 Founder and CEO Gerald Finken on the Role and Value of Pharmacists in Clinical Research
Manage episode 340316721 series 3335332
Вміст надано Clinical Research News. Весь вміст подкастів, включаючи епізоди, графіку та описи подкастів, завантажується та надається безпосередньо компанією Clinical Research News або його партнером по платформі подкастів. Якщо ви вважаєте, що хтось використовує ваш захищений авторським правом твір без вашого дозволу, ви можете виконати процедуру, описану тут https://uk.player.fm/legal.
Pharmacists demonstrate tremendous expertise in drug counseling and dispensation, so it seems undeniable that they should play a prominent role in clinical research. Surprisingly, their skill sets are rarely used in clinical trials. That’s why Founder and CEO Gerald Finken created RxE2, a community-based decentralized trial technology company spearheaded by pharmacists, offering primary stakeholders their rightful seat at the clinical research table.
In this episode, host Deborah Borfitz speaks with Finken about the challenges of delivering a new clinical trial concept and how the industry could benefit if pharmacists had more influence. He says, “I firmly believe that if pharmacists were involved, some of the issues that we’re having today in clinical trials wouldn’t exist. I don’t think recruitment would be a problem. I don’t think adherence and compliance would be a problem because pharmacists are medication experts who are trained to counsel patients and find out things real-time.” Finken also talks about the industry’s response to his new venture and the company’s plans to scale in the future.
Links from this episode:
Clinical Research News
RxE2
American Pharmacists Association
American Association of Pharmaceutical Scientists
26 епізодів
Поширити
